DK0573601T3 - Behandling af cellulitis med retinoider - Google Patents

Behandling af cellulitis med retinoider

Info

Publication number
DK0573601T3
DK0573601T3 DK92908452T DK92908452T DK0573601T3 DK 0573601 T3 DK0573601 T3 DK 0573601T3 DK 92908452 T DK92908452 T DK 92908452T DK 92908452 T DK92908452 T DK 92908452T DK 0573601 T3 DK0573601 T3 DK 0573601T3
Authority
DK
Denmark
Prior art keywords
cellulitis
retinoids
treatment
amount
cellulite
Prior art date
Application number
DK92908452T
Other languages
Danish (da)
English (en)
Inventor
Albert M Kligman
Original Assignee
Albert M Kligman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Albert M Kligman filed Critical Albert M Kligman
Application granted granted Critical
Publication of DK0573601T3 publication Critical patent/DK0573601T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/06Preparations for care of the skin for countering cellulitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07Retinol compounds, e.g. vitamin A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/671Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
  • Physical Vapour Deposition (AREA)
  • Indole Compounds (AREA)
  • Furan Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DK92908452T 1991-02-27 1992-02-26 Behandling af cellulitis med retinoider DK0573601T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/661,753 US5051449A (en) 1991-02-27 1991-02-27 Treatment of cellulite with retinoids
PCT/US1992/001541 WO1992015293A1 (fr) 1991-02-27 1992-02-26 Traitement de la cellulite avec des retinoides

Publications (1)

Publication Number Publication Date
DK0573601T3 true DK0573601T3 (da) 1999-06-23

Family

ID=24654977

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92908452T DK0573601T3 (da) 1991-02-27 1992-02-26 Behandling af cellulitis med retinoider

Country Status (17)

Country Link
US (1) US5051449A (fr)
EP (1) EP0573601B1 (fr)
JP (1) JP2893483B2 (fr)
KR (1) KR100224284B1 (fr)
AT (1) ATE172113T1 (fr)
AU (1) AU666303B2 (fr)
CA (1) CA2104452C (fr)
DE (1) DE69227306T2 (fr)
DK (1) DK0573601T3 (fr)
ES (1) ES2124725T3 (fr)
FI (1) FI103950B1 (fr)
HU (1) HU218914B (fr)
IE (1) IE920624A1 (fr)
NO (1) NO304727B1 (fr)
NZ (1) NZ241757A (fr)
SG (1) SG69981A1 (fr)
WO (1) WO1992015293A1 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5134163A (en) * 1989-09-01 1992-07-28 Kligman Albert M Methods of preventing and reducing the size of striae distensae lesions
US5521221A (en) * 1991-04-09 1996-05-28 Sloan-Kettering Institute For Cancer Research Retro-α-retinol (4,14-retro-retinol) derivatives and uses of retro-α-retinol
JP2765354B2 (ja) * 1992-03-09 1998-06-11 住友電装株式会社 接続具における電線の敷線方法
US5587396A (en) * 1994-08-26 1996-12-24 Mary Kay Inc. Method of ameliorating cellulite by disrupting the barrier function of the stratum corneum
CA2234968A1 (fr) * 1995-10-18 1997-04-24 Mary Kay Inc. Traitements structurels de la cellulite, par applications locales
US5720963A (en) * 1994-08-26 1998-02-24 Mary Kay Inc. Barrier disruption treatments for structurally deteriorated skin
US5529769A (en) 1994-12-20 1996-06-25 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic compositions containing betulinic acid
US5536499A (en) * 1995-02-24 1996-07-16 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic compositions for reducing or preventing signs of cellulite
US5523090A (en) * 1995-02-24 1996-06-04 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Skin treatment composition
AU722070B2 (en) * 1995-10-18 2000-07-20 Mary Kay Inc. Topically applied, structural cellulite treatments
US5837224A (en) * 1996-01-19 1998-11-17 The Regents Of The University Of Michigan Method of inhibiting photoaging of skin
US6008254A (en) 1997-05-09 1999-12-28 Kligman; Douglas E. Method of treating skin disorders with high-strength tretinoin
FR2767058B1 (fr) * 1997-08-05 2000-05-05 Centre Nat Rech Scient Utilisation d'un compose de type retinoide, notamment l'acide retinoique pour la preparation d' un medicament destine au traitement de l'obesite.
TWI234455B (en) * 1998-04-02 2005-06-21 Univ Michigan Methods and compositions for reducing UV-induced inhibition of collagen synthesis in human skin
US6683069B1 (en) 1998-04-02 2004-01-27 Regents Of The University Of Michigan Methods and compositions for reducing UV-induced inhibition of collagen synthesis in human skin
US6982284B1 (en) 1999-09-10 2006-01-03 Applied Genetics Incorporated Dermatics Compositions and methods for modification of skin lipid content
WO2004112689A2 (fr) * 2003-06-23 2004-12-29 Transpharma Medical Ltd. Systeme d'administration transdermique d'agents cosmetiques
FR2863492B1 (fr) * 2003-12-10 2007-08-24 Oreal Utilisation des modulateurs d'aquaglyceroporines comme amincissant
DE102004002606A1 (de) * 2004-01-15 2005-08-04 Beiersdorf Ag Visualisierung von Sonnenschutzmitteln auf der Haut
US20070025950A1 (en) * 2005-07-28 2007-02-01 Elson Melvin L Composition and method for treating cellulite
WO2008025368A1 (fr) * 2006-08-30 2008-03-06 Merck Patent Gmbh Utilisation de dérivés de chromén-4-one
EP1977743B1 (fr) 2007-03-20 2009-09-02 Johnson & Johnson Consumer France SAS Compositions contenant un retinoide et des dèrivés de l'acide beta-aminoisobutyrique
TWI395593B (zh) 2008-03-06 2013-05-11 Halozyme Inc 可活化的基質降解酵素之活體內暫時性控制
DE102010054149A1 (de) 2010-12-10 2012-06-14 Merck Patent Gmbh 2-Pyrone
KR102406880B1 (ko) 2015-10-30 2022-06-08 팀버 파마슈티칼스 엘엘씨 이소트레티노인 제형 및 이의 용도 및 사용 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3729568A (en) * 1969-09-23 1973-04-24 Johnson & Johnson Acne treatment
US4288633A (en) * 1980-04-03 1981-09-08 American Cyanamid Company 1-Hydroxymethyl-11-deoxy-16-hydroxy-prosten-1-ol-derivatives
US4877805A (en) * 1985-07-26 1989-10-31 Kligman Albert M Methods for treatment of sundamaged human skin with retinoids
US4603146A (en) * 1984-05-16 1986-07-29 Kligman Albert M Methods for retarding the effects of aging of the skin
US4888342A (en) * 1984-05-16 1989-12-19 Kligman Albert M Methods for treatment of sundamaged human skin with retinoids
US5019569A (en) * 1986-11-03 1991-05-28 Ortho Pharmaceutical Corporation Reversal of glucocorticoid-induced skin atrophy
AU636595B2 (en) * 1989-01-19 1993-05-06 Ortho Pharmaceutical Corporation Method for the treatment or prevention of intrinsically aged skin with retinoids
US5070108A (en) * 1990-10-12 1991-12-03 Trustees Of The University Of Pennsylvania Methods of treating osteoporosis, increasing bone mineral content and preventing the occurrence of compression fractures in a mammal
MX9201084A (es) * 1991-04-15 1992-12-21 Bristol Myers Squibb Co Hiper pigmentacion de la piel

Also Published As

Publication number Publication date
IE920624A1 (en) 1992-09-09
FI933736A0 (fi) 1993-08-25
CA2104452C (fr) 2002-07-16
AU666303B2 (en) 1996-02-08
HU9302437D0 (en) 1993-11-29
HUT65651A (en) 1994-07-28
KR100224284B1 (ko) 1999-10-15
FI103950B (fi) 1999-10-29
NO932949D0 (no) 1993-08-19
NO304727B1 (no) 1999-02-08
NZ241757A (en) 1994-04-27
DE69227306T2 (de) 1999-06-02
ES2124725T3 (es) 1999-02-16
WO1992015293A1 (fr) 1992-09-17
AU1644892A (en) 1992-10-06
NO932949L (no) 1993-08-19
FI933736A (fi) 1993-08-25
EP0573601A1 (fr) 1993-12-15
DE69227306D1 (de) 1998-11-19
CA2104452A1 (fr) 1992-08-28
EP0573601A4 (fr) 1994-01-12
FI103950B1 (fi) 1999-10-29
JPH06507395A (ja) 1994-08-25
ATE172113T1 (de) 1998-10-15
US5051449A (en) 1991-09-24
HU218914B (hu) 2000-12-28
EP0573601B1 (fr) 1998-10-14
SG69981A1 (en) 2000-01-25
JP2893483B2 (ja) 1999-05-24
KR930702992A (ko) 1993-11-29

Similar Documents

Publication Publication Date Title
DK0573601T3 (da) Behandling af cellulitis med retinoider
DE69029804D1 (de) VEHIKEL MIT LANGSAMER FREISETZUNG ZUR VERMINDERUNG DER HAUTREIZUNG TOPISCHER retinoidhaltiger MITTEL
DE69210515D1 (de) Kosmetisches Mittel
CA2145541A1 (fr) Composition cosmetique renfermant du retinol
ES2058517T3 (es) Composicion cosmetica.
BR9704529A (pt) Emulsão de óleo-emágua cosmética e processo para reduzir a irritação ou sensação de picada causada pela aplicação tópica de uma composição contendo um hidroxiácido ou um retinóide
CA2144509A1 (fr) Composition pour le conditionnement de la peau; methode de preparation et application
DE59410301D1 (de) Topische zubereitungen mit einem gehalt an l-arginin
NO973900L (no) Nitrogenoksyd syntase inhibitor
ATE290397T1 (de) Formulierung fur die wundheilung mit menschlichem plasma fibronektin
EP0197358A3 (en) Topical use of 3-phenylacetylamino-2,6-piperidinedione for treatment of skin wrinkles and hyperpigmentation
ATE158170T1 (de) Hautpflegemittel
NO920805L (no) Metoder for forhindring og redusering av stoerrelsen av striae distensae-lesjoner
DE69018570D1 (de) Wasserlösliche Vitamin A-Zubereitungen und deren Verwendung bei der Hautbehandlung.
AU3802289A (en) Treatment of periodontoclasia with retinoic acid
MX9703471A (es) Composicion cosmetica con esteres de acido graso retinol insaturado de cadena larga.
TH15130EX (th) ส่วนประกอบของเครื่องสำอางที่ใช้กับผิวหนังที่ก่อ ให้เกิดการระคายเคืองต่ำสำหรับใช้เฉพาะแห่งเป็น ประจำทุกวัน, การนำไปใช้และการผลิต